FR2603040B1 - PROTEIN, DNA SEQUENCE, POXVIRUSES, CELLS AND THEIR CULTURE PROCESS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USEFUL IN THE PREVENTION OF SCHISTOSOMOSIS - Google Patents

PROTEIN, DNA SEQUENCE, POXVIRUSES, CELLS AND THEIR CULTURE PROCESS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USEFUL IN THE PREVENTION OF SCHISTOSOMOSIS

Info

Publication number
FR2603040B1
FR2603040B1 FR8611986A FR8611986A FR2603040B1 FR 2603040 B1 FR2603040 B1 FR 2603040B1 FR 8611986 A FR8611986 A FR 8611986A FR 8611986 A FR8611986 A FR 8611986A FR 2603040 B1 FR2603040 B1 FR 2603040B1
Authority
FR
France
Prior art keywords
schistosomosis
poxviruses
protein
prevention
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8611986A
Other languages
French (fr)
Other versions
FR2603040A1 (en
Inventor
Paul Sondermeyer
Jean-Marc Balloul
Raymond Pierce
Jean-Marie Grzych
Marie-Paule Kieny
Gerard Loison
Andre Capron
Jean-Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR8611986A priority Critical patent/FR2603040B1/en
Priority to AU77170/87A priority patent/AU613583B2/en
Priority to DE3788852T priority patent/DE3788852T2/en
Priority to CA000545007A priority patent/CA1340839C/en
Priority to EP87401915A priority patent/EP0268501B1/en
Priority to AT87401915T priority patent/ATE100493T1/en
Priority to ES87401915T priority patent/ES2061521T3/en
Priority to DK198704380A priority patent/DK173779B1/en
Priority to JP62209104A priority patent/JP3127261B2/en
Priority to PH35714A priority patent/PH31198A/en
Priority to CN198787106696A priority patent/CN87106696A/en
Priority to KR870009208A priority patent/KR880002894A/en
Publication of FR2603040A1 publication Critical patent/FR2603040A1/en
Application granted granted Critical
Publication of FR2603040B1 publication Critical patent/FR2603040B1/en
Priority to US07/964,471 priority patent/US5597570A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
FR8611986A 1986-08-22 1986-08-22 PROTEIN, DNA SEQUENCE, POXVIRUSES, CELLS AND THEIR CULTURE PROCESS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USEFUL IN THE PREVENTION OF SCHISTOSOMOSIS Expired - Fee Related FR2603040B1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR8611986A FR2603040B1 (en) 1986-08-22 1986-08-22 PROTEIN, DNA SEQUENCE, POXVIRUSES, CELLS AND THEIR CULTURE PROCESS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USEFUL IN THE PREVENTION OF SCHISTOSOMOSIS
AU77170/87A AU613583B2 (en) 1986-08-22 1987-08-18 Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity
CA000545007A CA1340839C (en) 1986-08-22 1987-08-20 Proteins and process for preparing them, dna sequences, antibodies and uses thereof, posvirus, altered or infected cells, pharmaceutical compositions useful for the prevention of schistosomosis and uses thereof as an agent with a glutathion-s-transferase activity
EP87401915A EP0268501B1 (en) 1986-08-22 1987-08-20 Proteins having a glutathion-S-transferase activity, DNA sequences, antibodies, pox viruses and medicaments for the prevention of schistosomiasis
AT87401915T ATE100493T1 (en) 1986-08-22 1987-08-20 PROTEINS WITH GLUTATHIONE-S-TRANSFERASE ACTIVITY, DNA SEQUENCES, ANTIBODIES, POXVIRUS AND PHARMACEUTICALS FOR THE PREVENTION OF SCHISTOSOMIASIS.
ES87401915T ES2061521T3 (en) 1986-08-22 1987-08-20 PROTEINS WITH GLUTATION-S-TRANSFERASE ACTIVITY, DNA SEQUENCES, ANTIBODIES, POXVIRUSES AND MEDICINES FOR THE PREVENTION OF EQUISTOSOMIASIS.
DE3788852T DE3788852T2 (en) 1986-08-22 1987-08-20 Proteins with glutathione-S-transferase activity, DNA sequences, antibodies, poxviruses and drugs for the prevention of schistosomiasis.
JP62209104A JP3127261B2 (en) 1986-08-22 1987-08-21 Protein and its production method, DNA sequence, antibody and its use, poxvirus, transformed or infected cell, schistosomiasis preventive agent and use as glutathione S-transferase active agent
DK198704380A DK173779B1 (en) 1986-08-22 1987-08-21 Schistosome protein, DNA fragment encoding the protein, expression unit and viral vector containing the DNA fragment, cell transformed with the expression unit, pharmaceutical composition containing the protein or vector, use of the protein
PH35714A PH31198A (en) 1986-08-22 1987-08-21 Protein recognized by antibodies raised against native P28 of schitosoma mansoni.
CN198787106696A CN87106696A (en) 1986-08-22 1987-08-22 Protein and preparation method thereof, the order of ADN, antibody and uses thereof, poxvirus du is transformed or the cell that infects is used to prevent the medicament composition of schistosomicide, and as the purposes of the developer of glutathione-s-transferase activity
KR870009208A KR880002894A (en) 1986-08-22 1987-08-22 Protein and DNA sequence used as a chemobacteremia wax
US07/964,471 US5597570A (en) 1986-08-22 1992-10-21 Protein recognized by antibodies raised against native P28 of schistosoma mansoni

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8611986A FR2603040B1 (en) 1986-08-22 1986-08-22 PROTEIN, DNA SEQUENCE, POXVIRUSES, CELLS AND THEIR CULTURE PROCESS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USEFUL IN THE PREVENTION OF SCHISTOSOMOSIS

Publications (2)

Publication Number Publication Date
FR2603040A1 FR2603040A1 (en) 1988-02-26
FR2603040B1 true FR2603040B1 (en) 1990-01-26

Family

ID=9338458

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8611986A Expired - Fee Related FR2603040B1 (en) 1986-08-22 1986-08-22 PROTEIN, DNA SEQUENCE, POXVIRUSES, CELLS AND THEIR CULTURE PROCESS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USEFUL IN THE PREVENTION OF SCHISTOSOMOSIS

Country Status (1)

Country Link
FR (1) FR2603040B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1052011C (en) * 1994-05-12 2000-05-03 北京医科大学 Vaccin peptide of blood fluke
WO1997033613A1 (en) * 1996-03-14 1997-09-18 Board Of Trustees Of The University Of Illinois Parasite-derived anti-inflammatory immunomodulatory protein
SI1335987T2 (en) 2000-11-23 2016-10-28 Bavarian Nordic A/S Modified vaccinia ankara virus variant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570940B2 (en) * 1982-11-30 1988-03-31 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Process for producing poxvirus recombinants for expression offoreign genes

Also Published As

Publication number Publication date
FR2603040A1 (en) 1988-02-26

Similar Documents

Publication Publication Date Title
BE902750A (en) NEW GANGLIOSIDE DERIVATIVES.
FR2442054A1 (en) PURIFIED PROTEINS, IN PARTICULAR INTERFERON, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2518095B1 (en) NOVEL L-OXA-, THIA- AND AZA-SPIROCYCLO-BENZENE-ACETAMIDES AND BENZAMIDES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM
IT1238348B (en) PROCESS FOR THE PREPARATION OF GENETIC BUILDINGS FOR THE EXPRESSION OF THE NERVE GROWTH FACTOR IN EUCARIOT CELLS.
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
FR2598420B1 (en) NOVEL RETINOIC ANTIBIOTICS ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
FR2553409B1 (en) NOVEL BENZENESULFONYL-LACTAMES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ACTIVE SUBSTANCE OF PHARMACEUTICAL COMPOSITIONS
FR2605004B1 (en) NOVEL AMINO ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
BE905796A (en) HUMAN MANGANESE SUPEROXIDE DISMUTASE DNA, ITS EXPRESSION IN BACTERIA, AND HUMAN MANGANESE SUPEROXIDE DISMUTASE RECOVERY METHOD.
FR2625099B1 (en) PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS
BE885156A (en) PSORALENES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2603040B1 (en) PROTEIN, DNA SEQUENCE, POXVIRUSES, CELLS AND THEIR CULTURE PROCESS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USEFUL IN THE PREVENTION OF SCHISTOSOMOSIS
IT8919050A0 (en) PROCEDURE FOR THE INTRODUCTION OF EXOGENOUS DNA INTO THE SOMATIC AND GERM CELLS OF ANIMALS.
FR2636531B1 (en) NOVEL BENZYLIDENE-CYCLANONES DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS ANTIOXIDANTS AND SOLAR FILTERS, COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2573077B1 (en) NOVEL THIOSULFONATE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE884083A (en) NOVEL OXIME-ETHERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2598591B1 (en) PROCESS FOR THE CULTURE OF PROCARYOYES AND EUKARYOTES AND USE OF THE CELLS THUS PREPARED IN COSMETIC, FOOD COMPOSITIONS AND FORAGE SUPPLEMENTS
FR2582835B1 (en) QUINOLEIN DERIVATIVES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2636630B1 (en) NOVEL BENZOFURANNIC COMPOUNDS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND USE OF SUCH COMPOSITIONS
FR2631829B1 (en) FUNGAL EXOPOLYSACCHARIDES HAVING IMMUNOSTIMULANT ACTIVITY, PROCESS FOR OBTAINING SAME AND THERAPEUTIC COMPOSITION CONTAINING THEM
FR2595697B1 (en) BENZYL-PYRIMIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
FR2611497B1 (en) AGGLOMERATES, THEIR PREPARATION AND PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS CONTAINING THEM
FR2601951B1 (en) NOVEL TETRAHYDROCARBAZOLONES, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCESS FOR THEIR PREPARATION
FR2612774B1 (en) COSMETIC AND PHARMACEUTICAL COMPOSITIONS USED TO TREAT THE PROCESS OF ANDROGENOGENETIC ALOPECIA, CONTAINING AZELAIC ACID
FR2597498B1 (en) PROCESS FOR THE RETENTION AND MAINTAINING OF THE ACTIVITY OF MICROORGANISMS IN STRUCTURES CARRYING SAID ACTIVITY, RESULTING STRUCTURES AND THEIR ANALYTICAL AND BIOTECHNOLOGICAL APPLICATIONS

Legal Events

Date Code Title Description
ST Notification of lapse